TMO (STOCKS)
Thermo Fisher Scientific, Inc.
$595.850000
-7.160000 (-1.19%)
Prev close: $603.010000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Marc N. Casper
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $231,401.55M
- Employees
- 125,000
- P/E (TTM)
- 32.44
- P/B (TTM)
- 4.23
- Dividend Yield
- 29.85%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $46.34B |
| Benefits Costs and Expenses | $38.70B |
| Costs And Expenses | $38.19B |
| Operating Expenses | $38.19B |
| Selling, General, and Administrative Expenses | $9.03B |
| Research and Development | $1.40B |
| Other Operating Expenses | $27.76B |
| Operating Income/Loss | $8.15B |
| Income/Loss Before Equity Method Investments | $7.64B |
| Income/Loss From Continuing Operations After Tax | $7.04B |
| Income/Loss From Continuing Operations Before Tax | $7.64B |
| Income/Loss From Equity Method Investments | -$53.00M |
| Income Tax Expense/Benefit | $597.00M |
| Income Tax Expense/Benefit, Deferred | -$504.00M |
| Net Income/Loss | $6.99B |
| Net Income/Loss Attributable To Noncontrolling Interest | $21.00M |
| Net Income/Loss Attributable To Parent | $6.97B |
| Net Income/Loss Attributable To Redeemable Noncontrolling Interest | $34.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $6.97B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $18.61 |
| Diluted Earnings Per Share | $18.58 |
| Basic Average Shares | 1,120,000,000 |
| Diluted Average Shares | 1,122,000,000 |
| Assets | $113.17B |
| Current Assets | $23.37B |
| Inventory | $5.63B |
| Other Current Assets | $17.74B |
| Noncurrent Assets | $89.81B |
| Fixed Assets | $10.76B |
| Intangible Assets | $18.61B |
| Other Non-current Assets | $60.45B |
| Liabilities | $60.49B |
| Current Liabilities | $15.07B |
| Accounts Payable | $3.27B |
| Wages | $1.69B |
| Other Current Liabilities | $10.11B |
| Noncurrent Liabilities | $45.42B |
| Long-term Debt | $42.28B |
| Other Non-current Liabilities | $3.14B |
| Redeemable Noncontrolling Interest | $121.00M |
| Equity | $52.69B |
| Equity Attributable To Noncontrolling Interest | $7.00M |
| Equity Attributable To Parent | $52.68B |
| Temporary Equity | $121.00M |
| Liabilities And Equity | $113.17B |
| Net Cash Flow From Operating Activities | $9.01B |
| Net Cash Flow From Operating Activities, Continuing | $9.01B |
| Net Cash Flow From Investing Activities | -$12.03B |
| Net Cash Flow From Investing Activities, Continuing | -$12.03B |
| Net Cash Flow From Financing Activities | $2.42B |
| Net Cash Flow From Financing Activities, Continuing | $2.42B |
| Net Cash Flow | -$600.00M |
| Net Cash Flow, Continuing | -$600.00M |
| Comprehensive Income/Loss | $7.32B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $13.00M |
| Comprehensive Income/Loss Attributable To Parent | $7.30B |
| Other Comprehensive Income/Loss | $328.00M |